Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oryza tablet for reducing drug-induced xerostomia in patients with overactive or neurogenic bladder
TCTR20240715015Phase 3Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Jun 2021
- Countries
- 1
01
Overview
Phase 3, randomised trial in overactive bladder (OAB), neurogenic bladder and xerostomia (2 arms), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Primary endpoint: Primary xerostomia improvement. Started Jun 2021; status: completed.
02
Conditions
overactive bladder (OAB)neurogenic bladderxerostomia
Beyond the preview
Go deeper on TCTR20240715015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240715015.